Canada Pension Plan Investment Board’s PDL BioPharma, Inc. PDLI Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-185,853	Closed	-$401K	–	1520
2019 Q3	$401K	Buy	185,853 +185,843	+1,858,430%	+$497K	﹤0.01%	1064
2019 Q2	$0	Sell	10 -206,492	-100%	-$670K	﹤0.01%	1661
2019 Q1	$768K	Buy	+206,502	New	+$697K	﹤0.01%	1134
2018 Q1	–	Sell	-603,800	Closed	-$1.65M	–	1341
2017 Q4	$1.65M	Buy	603,800 +389,300	+181%	+$1.2M	﹤0.01%	923
2017 Q3	$727K	Sell	214,500 -1,299,138	-86%	-$3.61M	﹤0.01%	973
2017 Q2	$3.74M	Sell	1,513,638 -618,962	-29%	-$1.42M	0.01%	711
2017 Q1	$4.84M	Hold	2,132,600	–	–	0.01%	633
2016 Q4	$4.52M	Hold	2,132,600	–	–	0.02%	538
2016 Q3	$7.14M	Hold	2,132,600	–	–	0.03%	440
2016 Q2	$6.7M	Hold	2,132,600	–	–	0.03%	450
2016 Q1	$7.1M	Buy	2,132,600 +390,500	+22%	+$1.22M	0.03%	465
2015 Q4	$6.17M	Buy	1,742,100 +1,310,000	+303%	+$5.48M	0.03%	480
2015 Q3	$2.17M	Buy	+432,100	New	+$2.48M	0.01%	730

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board's PDLI Position: Q4 2019 in Review

Canada Pension Plan Investment Board sold out of PDL BioPharma, Inc. (PDLI) in Q4 2019, closing a stake of 185,853 shares — an estimated $401K sold.

Canada Pension Plan Investment Board first reported a position in PDLI in Q3 2015 and held it in 13 quarters. The position peaked at $7.14M in Q3 2016. 150 funds tracked by Wall St. Rank hold PDLI as of Q4 2019.

Canada Pension Plan Investment Board reported no remaining PDL BioPharma, Inc. position as of Q4 2019 after selling out during the quarter.
Canada Pension Plan Investment Board sold 185,853 PDL BioPharma, Inc. shares in Q4 2019, an estimated $401K.
Canada Pension Plan Investment Board first reported a position in PDL BioPharma, Inc. in Q3 2015 and held it in 13 quarters.
Canada Pension Plan Investment Board's PDL BioPharma, Inc. position peaked at $7.14M in Q3 2016.
150 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2019, filed 14 Feb 2020.